A new gold(III) complex bearing a 2-((2,20-bipyridin)-5-yl)-1Hbenzimidazol- 4-carboxamide ligand has been synthesized and characterized for its biological properties in vitro. In addition to showing promising antiproliferative effects against human cancer cells, the compound potently and selectively inhibits the zinc finger protein PARP-1, with respect to the seleno-enzyme thioredoxin reductase. The results hold promise for the design of novel gold-based anticancer agents disrupting PARP-1 function and to be used in combination therapies.

Toward anticancer gold-based compounds targeting PARP-1: A new case study

CITTA, ANNA;SCALCON, VALERIA;FOLDA, ALESSANDRA;RIGOBELLO, MARIA PIA;
2016

Abstract

A new gold(III) complex bearing a 2-((2,20-bipyridin)-5-yl)-1Hbenzimidazol- 4-carboxamide ligand has been synthesized and characterized for its biological properties in vitro. In addition to showing promising antiproliferative effects against human cancer cells, the compound potently and selectively inhibits the zinc finger protein PARP-1, with respect to the seleno-enzyme thioredoxin reductase. The results hold promise for the design of novel gold-based anticancer agents disrupting PARP-1 function and to be used in combination therapies.
File in questo prodotto:
File Dimensione Formato  
RSCAdv Au-PARP1 2016.pdf

accesso aperto

Tipologia: Published (publisher's version)
Licenza: Accesso libero
Dimensione 275.8 kB
Formato Adobe PDF
275.8 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3218049
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 10
social impact